Kyle Wathen

Kyle Wathen has a strong background in the field of data analysis and statistical research. Kyle is currently serving as the Vice President of Scientific Strategy & Innovation at Cytel since April 2021. Prior to this, they worked as the Senior Director and Head of Advanced Analytics at Gilead Sciences from January 2020 to April 2021. Kyle also held the position of Director - Quantitative Decision Strategies at Johnson & Johnson for a significant period from 2011 to 2020.

Before entering the pharmaceutical industry, Kyle gained experience in the private sector as the owner of BabyAdventureGear.com from 2007 to 2011. Kyle also worked as a Research Statistician at MD Anderson from 2005 to 2011. Additionally, they served as the Director of Web Stat Solutions, LLC from 2003 to 2011.

Kyle's career started with their roles at M.D. Anderson Cancer Center, where they initially worked as a Statistical Analyst from 2000 to 2002. During this time, they provided statistical analysis, developed simulation software, and created websites for clinical trial enrollment. Subsequently, they advanced to the position of Systems Analyst III from 2002 to 2004, where they primarily focused on developing biostatistical software and designing tools for clinical trial design.

Prior to their experience in the pharmaceutical and healthcare industries, Kyle worked as a Computer Specialist at USDA: Forest Service from 1997 to 2000. In this role, they developed genetic simulation software, conducted data analysis, and performed simulations to optimize tree orchard planning.

Overall, Kyle Wathen has a diverse and extensive background in statistical research, data analysis, and software development, with a focus on the healthcare and pharmaceutical industries.

Kyle Wathen earned their Ph.D. in Biostatistics from The University of Texas Health Science Center at Houston (UTHealth Houston) from 2001 to 2005. Prior to this, they attended Texas A&M University, though no specific degree or field of study information is available.